Market Value1,318,626,521
Total Holdings69
File Date2024-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ITCI / Intra-Cellular Therapies, Inc.
GLUE / Monte Rosa Therapeutics, Inc.
GSK / GSK plc - Depositary Receipt (Common Stock)
RARE / Ultragenyx Pharmaceutical Inc.
PRAX / Praxis Precision Medicines, Inc.
DYN / Dyne Therapeutics, Inc.
BDX / Becton, Dickinson and Company
ZVRA / Zevra Therapeutics, Inc.
MGNX / MacroGenics, Inc.
BRKR / Bruker Corporation
SLDB / Solid Biosciences Inc.
ATXS / Astria Therapeutics, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
VTYX / Ventyx Biosciences, Inc.
NRIX / Nurix Therapeutics, Inc.
SVRA / Savara Inc.
A / Agilent Technologies, Inc.
KALV / KalVista Pharmaceuticals, Inc.
GMED / Globus Medical, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
ITOS / iTeos Therapeutics, Inc.
BDTX / Black Diamond Therapeutics, Inc.
SLNO / Soleno Therapeutics, Inc.
IMNM / Immunome, Inc.
XENE / Xenon Pharmaceuticals Inc.
LXEO / Lexeo Therapeutics, Inc.
APGE / Apogee Therapeutics, Inc.
EXAS / Exact Sciences Corporation
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
QURE / uniQure N.V.
VYGR / Voyager Therapeutics, Inc.
FATE / Fate Therapeutics, Inc.
BMY / Bristol-Myers Squibb Company
JAZZ / Jazz Pharmaceuticals plc
NARI / Inari Medical, Inc.
AXSM / Axsome Therapeutics, Inc.
FULC / Fulcrum Therapeutics, Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
APLS / Apellis Pharmaceuticals, Inc.
PCRX / Pacira BioSciences, Inc.
INSP / Inspire Medical Systems, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
ALXO / ALX Oncology Holdings Inc.
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
DNLI / Denali Therapeutics Inc.
VERV / Verve Therapeutics, Inc.
INSM / Insmed Incorporated
PASG / Passage Bio, Inc.
CYTK / Cytokinetics, Incorporated
ATRA / Atara Biotherapeutics, Inc.
PRME / Prime Medicine, Inc.
CMRX / Chimerix, Inc.
PEN / Penumbra, Inc.
LQDA / Liquidia Corporation
AGIO / Agios Pharmaceuticals, Inc.
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
ALLO / Allogene Therapeutics, Inc.
PTCT / PTC Therapeutics, Inc.
DNTH / Dianthus Therapeutics, Inc.
JANX / Janux Therapeutics, Inc.
BMRN / BioMarin Pharmaceutical Inc.
ACLX / Arcellx, Inc.
SNY / Sanofi - Depositary Receipt (Common Stock)
RPHM / Reneo Pharmaceuticals, Inc.
RLMD / Relmada Therapeutics, Inc.
EW / Edwards Lifesciences Corporation
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
BHVN / Biohaven Ltd. Call
BCAX / Bicara Therapeutics Inc.
URGN / UroGen Pharma Ltd.
TARS / Tarsus Pharmaceuticals, Inc.
ANRO / Alto Neuroscience, Inc.
ZYME / Zymeworks Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
IMTX / Immatics N.V.
TENX / Tenax Therapeutics, Inc.
ESTA / Establishment Labs Holdings Inc.
GERN / Geron Corporation
IOVA / Iovance Biotherapeutics, Inc.
AVDL / Avadel Pharmaceuticals plc Put
ARDX / Ardelyx, Inc.
APLT / Applied Therapeutics, Inc.
GILD / Gilead Sciences, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.